FDA Adverse Event Malfunction Summary report: N

IV START PAK W/PERSIST, TEGADERM

MDR report key: 11402985 · Received March 3, 2021

Report

Report Number
9610847-2021-00089
Event Type
Malfunction
Date Received
March 3, 2021
Date of Event
February 4, 2021
Report Date
March 30, 2021
Manufacturer
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
Product Code
FPA
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MX
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: A COMPLAINT OF PRODUCT SPILLING WAS RECEIVED FROM THE CUSTOMER. A PHOTO WAS PROVIDED TO AID IN THE INVESTIGATION OF THIS DEFECT. THROUGH VISUAL INSPECTION THE CUSTOMER COMPLAINT WAS CONFIRMED. IT WAS OBSERVED THAT THE PERSIST SPILLED. A DEVICE HISTORY RECORD REVIEW WAS COMPLETED BY OUR QUALITY ENGINEER TEAM FOR PROVIDED LOT NUMBER 0092928. THE REVIEW DID NOT REVEAL ANY DETECTED ABNORMALITIES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THIS DEFECT AND ALL QUALITY TESTS WERE FOUND TO BE WITHIN SPECIFICATION. A ROOT CAUSE COULD NOT BE DETERMINED BECAUSE A SAMPLE WAS NOT RETURNED FOR INVESTIGATION. THIS IS THE FIRST COMPLAINT FOR PRODUCT SPILL ON MATERIAL 394910 & BATCH 0092928. H3 OTHER TEXT : SEE H.10.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE IV START PAK W/PERSIST, TEGADERM EXPERIENCED DAMAGED OR OPEN UNIT PACKAGING/SEAL WHERE STERILITY WAS COMPROMISED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: PRODUCT SPILL. MATERIAL: 386170. LOT: 0092928. QUANTITY: 1 EA.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE IV START PAK W/PERSIST, TEGADERM EXPERIENCED DAMAGED OR OPEN UNIT PACKAGING/SEAL WHERE STERILITY WAS COMPROMISED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: PRODUCT SPILL. MATERIAL: 386170. LOT: 0092928. QUANTITY: 1 EA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
304800 IV START PAK W/PERSIST, TEGADERM INTRAVASCULAR ADMINISTRATION SET FPA BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. 0092928

Patients

Seq Age Sex Outcome Treatment
1